Skip to main content
Clinical Trials/CTRI/2020/04/024825
CTRI/2020/04/024825
Recruiting
Phase 2

A randomized controlled study to evaluate the efficacy of hijamah bil shart and assessment of biomarkers in knee osteoarthritis patients

Jamia Hamdard0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M171- Unilateral primary osteoarthritisof knee
Sponsor
Jamia Hamdard
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1 Patients of all genders from age 40 to 65 years
  • 2 Patients with pain intensity score of 30 mm or more on a 100\-mm visual analog scale(VAS)
  • 3 Patients with a Kellgren \& Lawrence grade of 2 and 3 on X ray Knee joint
  • 4 Clinically stable patients
  • 5 Patients with a BMI ââ?°Â¤30kg/m2
  • 6 Willingness and ability to accept wet cupping intervention and to comply with the requirements of the study protocol

Exclusion Criteria

  • 1 Patients of bleeding disorders
  • 2 Patients taking anticoagulants
  • 3 Patients of anemia (Hb \< 9gm% )
  • 4 Pregnant and lactating females
  • 5 History of severe hypertension ,CKD, CLD and patient having HbA1c \> 7
  • 6 History of significant trauma, infection or presence of hematoma at the site of knee and/or knee surgery
  • 7 OA of other joints other than knee
  • 8 History of Gout, RA, Pagets disease or any other musculo\- skeletal disorder
  • 9 HbsAg, HIV, HCV positive patients
  • 10 History of malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials